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Alterations in dopamine receptor type 1 (D1R) density are associated with cognitive deficits of aging and schizophrenia. In the
prefrontal cortex (PFC), D1R plays a critical role in the regulation of working memory, which is impaired in these cognitive
deficit states, but the cellular events triggered by changes in D1R expression remain unknown. A previous report
demonstrated that interaction between voltage-gated calcium channel type 2.2 (CaV2.2) and D1R stimulates CaV2.2
postsynaptic surface location in medial PFC pyramidal neurons. Here, we show that in addition to the occurrence of the physical
receptor-channel interaction, constitutive D1R activity mediates up-regulation of functional CaV2.2 surface density. We
performed patch-clamp experiments on transfected HEK293T cells and wild-type C57BL/6 mouse brain slices, as well as
imaging experiments and cAMP measurements. We found that D1R coexpression led to ∼60% increase in CaV2.2 currents in
HEK293T cells. This effect was occluded by preincubation with a D1/D5R inverse agonist, chlorpromazine, and by replacing
D1R with a D1R mutant lacking constitutive activity. Moreover, D1R-induced increase in CaV2.2 currents required basally
active Gs protein, as well as D1R-CaV2.2 interaction. In mice, intraperitoneal administration of chlorpromazine reduced native
CaV currents’ sensitivity to ω-conotoxin-GVIA and their size by ∼49% in layer V/VI pyramidal neurons from medial PFC,
indicating a selective effect on CaV2.2. Additionally, we found that reducing D1/D5R constitutive activity correlates with a
decrease in the agonist-induced D1/D5R inhibitory effect on native CaV currents. Our results could be interpreted as a
stimulatory effect of D1R constitutive activity on the number of CaV2.2 channels available for dopamine-mediated
modulation. Our results contribute to the understanding of the physiological role of D1R constitutive activity and may explain
the noncanonical postsynaptic distribution of functional CaV2.2 in PFC neurons.
Introduction
Dopamine receptors constitute a family of G protein–coupled
receptors (GPCRs) that are widely expressed in the brain and
contribute to diverse neuronal functions. In particular, the D1-
like receptor subfamily, which includes the dopamine receptor
type 1 (D1R) and D5R, plays a key role in locomotor activity
(Svensson et al., 2017) and cognitive and social behaviors (Cools,
2008; Homberg et al., 2016). The effects of D1/D5R stimulation
by agonists have been thoroughly studied in behavioral tests in
rodents (Zahrt et al., 1997; Stubbendorff et al., 2019) and pri-
mates (Sawaguchi and Goldman-Rakic, 1991; Arnsten et al.,
2015). Moreover, there is strong evidence that different physi-
ological and pathological states greatly correlate with changes in
D1/D5R expression levels. For instance, in bird neurons, D1-like
receptor mRNA increases after working memory training, while
D2R mRNA remains unchanged (Herold et al., 2012). In human
brains, alterations in D1/D5R receptor density and sensitivity to
dopamine are associated with cognitive deficits of aging and
schizophrenia (Wang et al., 1998; Thompson et al., 2014). Do-
pamine binding to D1/D5R receptors also changes after working
memory training in humans (McNab et al., 2009). While many
studies have examined these behavioral effects related to al-
terations in D1/D5R receptor properties, the downstream cellu-
lar events triggered by these changes remain unknown.
D1/D5R regulate workingmemory processes by actingmainly
in the prefrontal cortex (PFC) in rodents and primates (Jones,
2002; Williams and Castner, 2006), and their expression
levels in this brain area are dramatically impaired in cognitive
deficit states (Goldman-Rakic et al., 2004). In particular,
several studies have established a relationship between im-
proved cognitive test performance in mice and higher levels of
D1R protein specifically in the medial PFC (mPFC; Kolata et al.,
2010; Wass et al., 2013, 2018). A recent report found that the
origin of this D1R increase is related to the DRiP78 chaperonin
(Wass et al., 2018), but their cellular targets are unknown.
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Meanwhile, D1R physically interacts with voltage-gated cal-
cium channel type 2.2 (CaV2.2) and increases channel protein
density at postsynaptic sites of mPFC pyramidal neurons
(Kisilevsky et al., 2008). Higher activity-mediated calcium
influx could thus represent a cellular consequence of in-
creased D1R expression levels. Here, we aimed to understand
the underlying mechanisms and functional output of CaV2.2
modulation by D1R.
A relevant feature of D1R that could be involved in the in-
crease in CaV2.2 in the plasma membrane is the receptor’s
constitutive activity. The importance of GPCR agonist indepen-
dent activity is becoming increasingly clear (Costa and Cotecchia,
2005; Meye et al., 2014). For instance, our laboratory has dem-
onstrated that constitutive activity of two different GPCRs has
a great impact on calcium channel function (López Soto et al.,
2015; Agosti et al., 2017; Mustafá et al., 2017; Mart́ınez Damonte
et al., 2018). For D1/D5R, there is an abundance of in vitro reports
demonstrating a basal increase in Gs activity in several systems
(Plouffe et al., 2010; Zhang et al., 2014; Zhang et al., 2015). Our
studies extend the role of D1R constitutive activity in a physio-
logically relevant event: the stimulation of mPFC native and
recombinant CaV2.2 currents by D1R expression. Moreover, we
have combined the study of dopamine-mediated activity with
the exploration of the role of D1R constitutive activity to
modulate CaV2.2 to propose a compelling model that expands
our understanding of D1R function in the brain.
Materials and methods
Animals and ethical approval
All experiments in this study received approval from the ethical
committee of the Multidisciplinary Institute of Cell Biology
(IMBICE), in strict accordance with the recommendations of the
U.S. Guide for the Care and Use of Laboratory Animals of the
National Research Council (reference number from the Ethical
Committee of IMBICE; #12-03-19). All possible actions to mini-
mize suffering were taken. Experiments were conducted on
C57BL/6 WT mice of both sexes. Mice were bred and housed at
the IMBICE animal facility with a 12-h light/dark cycle, con-
trolled room temperature (22°C ± 2°C), and ad libitum access to
food and water.
Animal treatment and PFC slice preparations
A total of 18 mice were used in this study (vehicle, n = 11;
chlorpromazine-treated, n = 7). 4–6-wk-old WT mice were
treated with vehicle (saline solution NaCl 0.9%) or chlorprom-
azine (1 mg/kg) through two intraperitoneal (IP) injections
(0.1 ml/10 g) 24 h and 1 h before sacrifice. Mice were anaes-
thetized with isoflurane (2%) and immediately decapitated.
Brains were quickly removed and immersed in ice-cold 95% O2
and 5% CO2-equilibrated cutting solution containing (inmM) 110
choline chloride, 25 glucose, 25 NaHCO3, 7 MgCl2, 11.6 ascorbic
acid, 3.1 sodium pyruvate, 2.5 KCl, 1.25 NaH2PO4, and 0.5 CaCl2,
pH 7.4, with CsOH. Coronal brain slices including the mPFC
(∼300 µM, 1.5–2.5 mm anterior to bregma) were obtained using
a vibratory tissue slicer (PELCO easiSlicer; #11000; Ted Pella
Inc.) and then transferred to an incubation chamber filled with
95% O2, 5% CO2–equilibrated artificial cerebrospinal fluid (aCSF)
containing (in mM) 124 NaCl, 26.2 NaHCO3, 11 glucose, 2.5 KCl,
2.5 CaCl2, 1.3 MgCl2, and 1 NaH2PO4, pH 7.4, with HCl. Slices
were maintained at 37°C for 15 min and left to recover at room
temperature (∼24°C) for 30 min before recordings.
Cell culture and transient transfections
HEK293T cells were grown in Dulbecco’s modified Eagle’s me-
dium (DMEM; #D5030, Gibco; Thermo-Fisher) with 10% FBS
(Internegocios A.S.) and subcultured when 80% confluence was
reached. For patch-clamp experiments, HEK293T cells were
cotransfected with plasmids containing human D1R (DRD1;
GenBank accession no. NM000794), kindly provided by Dr. M.
Tiberi (University of Ottawa, Ottawa, ON, Canada), the human
D1RS199A (Al-Fulaij et al., 2008), and voltage-gated calcium
channel subunit CaV2.2 (Cacna1b; GenBank accession no.
AF055477) with auxiliary subunits CaVβ3 (Cacnb3; GenBank ac-
cession no. M88751) and CaVα2δ1 (Cacna2d1; GenBank accession
no. AF286488). Cells were cotransfected with a fixed amount of
CaV2.2 and the following increasing amounts of D1R cDNA: 11, 17,
and 23 ng per well (equivalent to D1R:CaV2.2 molar ratios of
0.05, 0.075, and 0.1, respectively). For some experiments, cells
were additionally transfected with plasmids containing cDNA
encoding a peptide corresponding to the D1R loop 1, D1R loop 2,
or C terminus of CaV2.2 (0.2 µg cDNA transfected per well for
saturating expression). For live imaging experiments, YFP-
tagged versions of D1R and D1RS199A mutant were used. All
transient transfections were conducted using Lipofectamine
2000 (#11668019, Invitrogen; Thermo-Fisher) and, whenever
necessary, an enhanced GFP (eGFP) containing plasmid to
identify transfected cells and the empty plasmid pcDNA3.1 (+) to
complete the total cDNA amount in the transfection mix were
added. Transfected HEK293T cells were kept in culture for 24 h
to allow expression, then dispersed with 0.25 mg/ml trypsin,
rinsed twice, and kept in DMEM at room temperature during
patch-clamp experiments.
For FRET time course of cAMP intracellular level experi-
ments, stable HEK293T-expressing pcDNA3.1/Zeo(1)-mTur-
quoise2-EPAC-cp173Venus-Venus (Epac-S H187) (HEKT Epac-S
H187) cells were obtained by transfection of HEK293T using the
K2 Transfection System (Biontex). 24 h after transfection, cells
were seeded in the presence of 25 µg/ml Zeocin (InvivoGen) for
2 wk, and clonal selection was performed in 96-well plates for
2 wk. Clones were tested for Epac-S H187 by fluorescence
spectra (450–650 nm) measurements in a FlexStation 3 Multi-
Mode Microplate Reader (Molecular Devices) with excitation at
430 nm. The HEKT Epac-S H187 clone with higher fluorescence
emission was chosen for further experiments. The stable clone
was grown in DMEM medium supplemented with 10% FBS,
50 µg/ml gentamicin, and 12.5 µg/ml Zeocin. For transient
transfections, HEK293T and HEKT Epac-S H187 cells were
grown to 80–90% confluency. cDNA constructs were transfected
into cells using the K2 Transfection System. The transfection
protocol was optimized as recommended by the supplier. Assays
were always performed 48 h after transfection. The expression
of the constructs was confirmed by immunoblotting using
specific antibodies. The mTurquoise2-EPAC-cp173Venus-Venus
McCarthy et al. Journal of General Physiology 2 of 13




 https://rupress.org/jgp/article-pdf/152/5/e201912492/1041700/jgp_201912492.pdf by guest on 10 June 2020
(Epac-S H187) construct was provided by Dr. KeesJalink (Cell
Biophysics and Imaging Group, Netherlands Cancer Institute,
Amsterdam, Netherlands; Klarenbeek et al., 2011).
Cloning
Plasmids containing cDNA encoding the D1R loop 1 (including
amino acids 52–57) or D1R loop 2 (including amino acids 118–138)
peptides were kindly provided by Dr. G. Zamponi (University of
Calgary, Calgary, AB, Canada), originally included in pGEX-5.1
bacterial expression vectors. To express D1R loop 1 and D1R loop
2 in a mammalian system, the sequences for D1R loop 1 and D1R
loop 2 were cloned by blunt ligation into a pcDNA6 vector
backbone containing IRES-eGFP. The previously characterized
D1RS199A mutant (Al-Fulaij et al., 2008) was generated through
directed mutagenesis using the commercial plasmid containing
the human D1R (#DRD0100000; cDNA Resource Center, Uni-
versity ofMissouri). To generate YFP-tagged versions of D1R and
D1RS199A mutant, the sequences without stop codon were am-
plified by PCR with a sense oligonucleotide containing an EcoRI
site and an antisense oligonucleotide containing a BamHI site.
The PCR fragment was digested with EcoRI and BamHI and in-
serted into EcoRI and BamHI sites of PRK6-YFP vector. The
proximal portion of the CaV2.2 C terminus was amplified by PCR
with a sense oligonucleotide primer containing BamHI, an ATG
codon 5207–5222, and nucleotides 5207–5222 of CaV2.2 and
antisense oligonucleotide primer containing a PsyI site followed
by a stop codon and nucleotides 6037–6023 of CaV2.2. The se-
quence for the proximal portion of the CaV2.2 C terminus was
subcloned into pcDNA6 vector backbone containing IRES-eGFP.
All the final constructs were Sanger-sequenced by Macrogen.
Drugs
The commercial antipsychotic drug chlorpromazine (chlor-
promazine HCl, 25 mg/ml injectable blister, CAS #50–53-3; Lab-
oratorios Duncan S.A.) was donated by Dr. Martinez Mónaco and
Dr. Pinedo (Italian Hospital of La Plata, Buenos Aires, Argentina)
and used for IP injections in mice and 20-h preincubations of
transfected HEK293T cells. Chlorpromazine stock solution was
stored at room temperature, protected from light, and dissolved in
saline solution 0.9% NaCl <24 h before IP injections. For patch-
clamp recordings from mouse mPFC slices, the sodium channel
blocker tetrodotoxin (1 µM; CAS #4368–28-9, #T8024; Sigma-
Aldrich), the CaV2.2 blocker ω-conotoxin-GVIA (1 µM; CAS
#106375–28-4, #C-300; Alomone Labs), dopamine hydrochloride
(CAS #62–31-7, #H8502; Sigma-Aldrich), (±)-1-phenyl-2,3,4,5-
tetrahydro-(1H)-3-benzazepine-7,8-diol hydrochloride (SKF-
38393; 10 µM; CAS #62–717-42-4, #D047; Sigma-Aldrich), and
(−)-quinpirole hydrochloride (40 µM; CAS #85798–08-9, #Q102;
Sigma-Aldrich) were used. Dopamine was also used in patch-
clamp experiments in HEK293T cells. Cholera toxin (ChTx;
500 ng/ml; CAS #9012–63-9, #C8052; Sigma-Aldrich) was used
for 20-h preincubations in transfected HEK293T cells in order to
block Gs protein activity.
Electrophysiology
Calcium channel currents were recorded with either an EPC7
(HEKA Electronik) or an Axopatch 200 (Molecular Devices)
amplifier. Datawere sampled at 20 kHz and filtered at 10 kHz (−3 dB)
using either PatchMaster (HEKA Electronik) or pCLAMP8.2
(Molecular Devices) software. Access resistance and input re-
sistance were monitored by a step of −10 mV. Recordings in
which the access resistance increased by >20% were discarded.
Leak current was subtracted online using a P/−4 protocol, and
recordings with leak currents over 150 pA at holding potential
were discarded.
Native calcium currents of mPFC pyramidal neurons
Acute coronal mouse brain slices were transferred to the re-
cording chamber and visualized with an upright Zeiss Exam-
iner.A1 microscope (#491404–0001-000), a digital camera
(Rolera Bolt Scientific CMOS; QImaging), and Micro-Manager
1.4 open source microscopy software (Vale Lab, University of
California, San Francisco). Layer V/VI pyramidal neurons of the
mPFC were identified by localization and morphology (Wang
et al., 2006). Whole-cell patch-clamp recordings in voltage-
clamp mode were conducted at room temperature (∼24°C) in
the previously described aCSF (2.5mMCa2+) under a continuous
flow rate of 2.5 ml/min. Recording electrodes with resistances
between 3 and 6 MΩ were used and filled with internal solution
containing (in mM) 115 Cs-methanesulfonate, 20 tetraethylam-
monium chloride, 10 CsCl, 5 NaCl, 10 HEPES, 10 EGTA, 4 Mg-
ATP, and 0.3 Na-GTP, pH 7.4, with CsOH.
For native calcium current recordings, tetrodotoxin (1 µM)
was added to normal aCSF (2.5 mMCa2+) to block native voltage-
gated sodium channels. Neurons were held at resting potential
(−80 mV), and native calcium currents were evoked applying
square pulses from −80 to 0 mV (60-ms duration), with a sub-
sequent step at −60 mV (30-ms duration) before returning to
resting potential. Additionally, the specific CaV2.2 blocker
ω-conotoxin-GVIA (1 µM) was added to analyze CaV2.2 con-
tributions to total native calcium currents. Whenever indicated,
10 µM dopamine, 10 µM SKF38393, 40 µM quinpirole, or 10 µM
chlorpromazine was acutely applied to the bath solution.
Calcium currents in transiently transfected HEK293T cells
Whole-cell patch-clamp recordings were performed in
transfected HEK293T cells in voltage-clamp mode. Recording
electrodes with resistances between 2 and 5 MΩ were used
and filled with internal solution containing (in mM) 134 CsCl,
10 HEPES, 10 EGTA, 4 MgATP, and 1 EDTA, pH 7.4, with CsOH.
All recordings were conducted at room temperature (∼24°C)
with an external solution containing (in mM) 140 choline
chloride, 10 HEPES, 1 MgCl2.6H2O, and 2 CaCl2.H2O, pH 7.4,
with CsOH. To evoke ionic CaV2.2-mediated currents in
HEK293T cells, square pulses from −100 to 10 mV (30-ms
duration) followed by a step at −60 mV (10-ms duration) were
used. Cells were held at −100 mV as resting potential. ON
gating current recordings were performed with square pulses
from −100 mV to the reversal potential. The reversal potential
was determined by calculating the 0 current point in a
current-voltage curve built with square voltage pulses (5-ms
duration) from −100 to 55–70 mV every 0.5 mV. The datasets
for each experimental condition were obtained from at least
three independent experiments.
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Imaging
24 h after transfection with D1R-YFP (11 or 23 ng of cDNA per
well) or D1RS199A-YFP (23 ng per well), cells were washed twice
with 1× PBS, and 0.5 ml of 1 µg/ml membrane marker solution
(CellMask orange plasma membrane stain; Molecular Probes)
was added for 1 min, then cells were washed a third time with
PBS. Finally, the PBS was removed, and a clean coverslip was
placed over the cell layer. Fluorescence photomicrographs were
obtained using an optical epifluorescence microscope (Eclipse
Nikon 50i) at 60× magnification (0.80-mm numerical aperture),
equipped with B2A and G2A filters and a camera (DS-Ri1; Nikon
Corp.). Image acquisitionwas performed using the Nis-Elements
F 3.2 software (Nikon Corp.). FIJI ImageJ open source software
was used to analyze the photomicrographs and to calculate total
green fluorescence intensity, which was normalized by cell area.
The datasets for each experimental condition were obtained
from at least three independent experiments.
FRET time course of intracellular cAMP (i-cAMP)
FRET time course of cAMP intracellular levels was measured as
previously described (Carozzo et al., 2019). Briefly, HEKT Epac-S
H187 cells transfected with D1R, D1R plus D1R loop 2, or empty
pcDNA3.1 (+) plasmid was seeded in 96-well plates at a density of
105 cells per well. Before each experiment was started, cells were
washed with 0.9% NaCl twice, and 100 µl of FluoroBrite DMEM
(Thermo-Fisher) was added to each well before placing the plate
in a FlexStation 3 at 37°C. To determine i-cAMP response, the
baseline fluorescence signal detected at 475 nm (donor) and 530
nm (FRET) emission with excitation at 430 nm was measured.
Using the on-board pipettor, 50 µl of dopamine or chlorprom-
azine 3 µM stock solution (to reach a final concentration of 1 µM
in the well) or FluoroBrite DMEMwas added after 40 s, and then
the signals were monitored every 20 s for a total of 600 s. FRET
and donor intensities were measured for each time point. FRET/
donor ratio was calculated and normalized to basal levels before
stimulation (R/R0) for each time point. An area under the curve
value of 9-min R/R0 i-cAMP response was calculated for each
replicate.
Basal i-cAMP measurement
cAMP levels measured in HEK293T cells transfected with D1R,
D1R plus D1R loop 2, or empty pcDNA3.1 (+) were performed as
in Agosti et al. (2017). Briefly, 24 h after transfections, the su-
pernatants were removed, and 0.8 ml of ethanol was added to
each well. Ethanol was dried out, and residues were re-
suspended with 50 mM Tris-HCl, pH 7.4, with 0.1% BSA. cAMP
Figure 1. CaV currents from mPFC neurons are sensitive to D1/D5R constitutive and agonist-evoked activity. (A) Schematic coronal slice of a mouse
brain containing the mPFC (1.75 mm anterior to bregma), showing the location of the patch pipette in layer V of the mPFC (dark gray area). Inset shows an
infrared differential interference contrast image illustrating a recorded layer V/VI pyramidal neuron. Scale bar represents 10 µm. (B) Representative time
courses and averaged values of percentage of CaV current (ICa) inhibition from mPFC neurons by dopamine (+DA; 10 µM; n = 4, three animals) and SKF38393
(+SKF; 10 µM; n = 5, three animals). (C) Representative time course of ICa and averaged values for the percentage of ICa inhibition from mPFC neurons by
subsequent application of quinpirole (QP; 40 µM) and dopamine (+DA; 10 µM; n = 3, two animals). (D) Representative traces and averaged normalized ICa
registered in mPFC of mice treated IP with vehicle (n = 23, eight animals) or chlorpromazine (CPZ; 1 mg/kg; n = 6, four animals). (E) Representative time courses
of ICa and averaged percentage of inhibition of ICa by acute application of ω-conotoxin GVIA (cono; 1 µM) from mPFC neurons of mice treated IP with vehicle
(n = 10, six animals) or CPZ (1 mg/kg; n = 5, four animals). (F) Representative time course of ICa and averaged values for the percentage of inhibition of ICa from
mPFC neurons by subsequent application of 10 µM CPZ and 10 µM dopamine (+DA; n = 4, three animals). Student’s unpaired (B, D, and E) and paired (C and F)
t test. n.s., nonstatistically significant. Data were expressed as mean ± SEM, and dots represent individual data points.
McCarthy et al. Journal of General Physiology 4 of 13
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content was determined by a competitive radio-binding assay
for PKA using [3H]-cAMP as previously described (Davio et al.,
1995). The standard curve was performed using eight cAMP
concentrations ranging from 0.1 to 90 pmol. Duplicate samples
in at least three independent experiments were analyzed.
Statistics
Data were analyzed and visualized using OriginPro 8 (Origin-Lab
Corp.) and Prism 6 (GraphPad Software Inc.) software. We used
the Kolmogorov–Smirnov test for conformity to a normal distri-
bution, and variance homogeneity was examined using Bartlett’s
(normally distributed data) and Brown–Forsythe’s (nonnormally
distributed data) tests. P values were calculated from Student’s
paired and unpaired t test and multiple comparisons one-way AN-
OVA with Dunn’s or Tukey’s post hoc tests (normally distributed
data) or from the Mann–Whitney test or Kruskal–Wallis test with
Dunn’s post hoc test (nonnormally distributed data). Concentration-
response curves for dopaminewere fittedwithHill equations. Lineal
regressions for area under the gating current recorded for each cell
(QON) versus peak tail current were compared by extra sum-of-
squares F test. The specific statistical test used and sample size for
each dataset are indicated in the figure legends, including P values.
Data were expressed as mean ± SEM, and dots represent individual
data points.
Results
Chlorpromazine, a D1/D5R inverse agonist, reduces total CaV
currents in mPFC neurons
First, we tested the hypothesis that D1R constitutive activity plays a
role in controlling CaV2.2 current density in mPFC neurons. We
obtained acute coronal brain slices and recorded native CaV cur-
rents from layer V/VI pyramidal neurons of the mPFC (Fig. 1 A).
We first ran control experiments to assay the capability of D1/D5R
to modulate CaV currents by comparing the effect of acute appli-
cation of dopamine (10 µM) and SKF38293 (SKF; 10 µM), a specific
D1/D5R agonist. We found that these two agonists equally reduced
the currents (Fig. 1 B). Moreover, dopamine in the presence of
40 µM quinpirole, a D2R agonist, had a similar effect (Fig. 1 C).
Thus, we conclude that D1/D5R are the main dopamine receptor
subtypes modulating CaV currents in mPFC neurons. To study D1/
D5R constitutive activity, we took advantage of the fact that several
antipsychotic drugs, including chlorpromazine, have been shown
to act not only as D2R antagonists but also as inverse agonists of D1/
D5R (Cai et al., 1999). Therefore, we evaluated if pretreatment with
chlorpromazine is capable of reducing CaV2.2 currents in mPFC
pyramidal neurons.We performed two consecutive IP injections in
mice with 1 mg/kg chlorpromazine or vehicle 24 h and 1 h before
the experiment and found that native CaV currents from
chlorpromazine-treated mice were significantly smaller than cur-
rents from vehicle-treated mice (∼51% of the total current in
control; Fig. 1 D). Next, we assessed the contribution of CaV2.2 to
the total calcium current affected by chlorpromazine and found
that the sensitivity of CaV currents to 1 µM ω-conotoxin GVIA was
dramatically reduced from∼18% to∼2% in chlorpromazine-treated
mice, suggesting that inhibiting D1/D5R constitutive activity re-
duces CaV2.2 currents (Fig. 1 E). Finally, we explored the effect of
acute subsequent bath application of chlorpromazine and dopa-
mine on CaV currents from vehicle-treated mice. We found no
effect of chlorpromazine, indicating the requirement of an ex-
tended period of time for this effect, and 20% of CaV current in-
hibition by dopamine, similar to the values obtained in panels B
Figure 2. The sole expression of D1R in-
creases CaV2.2 currents in transfected HEK293T
cells. (A) Photomicrographs and average YFP
fluorescence (D1R-YFP F) in the plasma membrane
(PM) normalized by cell area in HEK293T cells co-
transfected with CaV2.2, CaVα2δ1, CaVβ3, and two
different amounts of D1R-YFP (11 and 23 ng cDNA
per well, equal to 0.05 and 0.1 D1R:CaV2.2 molar
ratios, respectively). Green and red signals originate
from the YFP tag on D1R and the PM marker Cell-
Mask (PM marker), respectively. Scale bar repre-
sents 1 µm. (B) Representative traces and averaged
CaV2.2 currents (ICav2.2) from HEK293T cells co-
transfected with CaV2.2, CaVα2δ1, CaVβ3, and in-
creasing amounts of D1R (0–23 ng cDNA per well).
Student’s unpaired t test (A) and Kruskal-Wallis test
with Dunn’s post-test versus 0 ng D1R (B). n.s.,
nonstatistically significant. Data were expressed as
mean ± SEM, and dots represent individual data
points.
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and C (Fig. 1 F). In summary, our data suggest that pyramidal
neurons from mPFC display lower CaV2.2 currents when D1/D5R
constitutive activity is reduced.
D1R coexpression increases CaV2.2 currents in transfected
HEK293T cells
To study the effect of D1R coexpression on isolated CaV2.2 cur-
rents, we used a heterologous expression system that we pre-
viously proved effective for studying the agonist-independent
activity of other GPCRs (López Soto et al., 2015; Agosti et al.,
2017). We cotransfected HEK293T cells with two different
amounts of YFP-tagged D1R (D1R-YFP) cDNA and a fixed amount
of CaV2.2 and its auxiliary subunits. We first confirmed that
increasing the amount of transfected D1R-YFP cDNA signifi-
cantly increased the total fluorescence intensity (Fig. 2 A). Next,
we evaluated the size of CaV2.2 currents in cells transfected with
a range of D1R cDNA and found that increasing the amount of
D1R cDNA dramatically increased CaV2.2 currents (Fig. 2 B).
Thus, we found that higher D1R expression levels led to in-
creased CaV2.2 basal currents.
Agonist-independent activity of D1R increases CaV2.2 currents
Assuming that each D1R molecule displays a fixed level of con-
stitutive activity, our data presented in Fig. 2 allow us to propose
that D1R agonist–independent activity contributes to positively
modulate CaV2.2 currents. We therefore tested if preincubation
with the D1/D5R inverse agonist chlorpromazine prevents this
stimulatory effect. Indeed, we found that 10 µM chlorpromazine
preincubation occludes CaV2.2 current increase by D1R coex-
pression, while having no effect on control currents (Fig. 3).
On the other hand, the drug failed to directly affect CaV2.2
currents, as we found no effect of acute application of chlor-
promazine at the concentration used for preincubation in cells
expressing only CaV2.2 (percent ICaV2.2 inhibition by 10 µM
chlorpromazine = 2.6 ± 1.0%; n = 5; nonstatistically significant
from zero, one-sample t test). We ran additional control ex-
periments to confirm that D1R is functional in our system and
the lack of effect from acute application of chlorpromazine on
D1R- and CaV2.2-expressing cells. We found that dopamine
application inhibits CaV2.2 currents in a concentration-
dependent manner. Moreover, increasing the amount of D1R
cDNA in the transfection mix had no effect on dopamine-
mediated inhibition. Finally, we failed to observe an effect
Figure 3. Chlorpromazine occludes D1R-induced increase in CaV2.2
currents in transfected HEK293T cells. Representative traces and averaged
CaV2.2 currents (ICav2.2) from HEK293T cells cotransfected with CaV2.2,
CaVα2δ1, CaVβ3, and either D1R (+D1R −CPZ; n = 12) or empty plasmid (−D1R
−CPZ; n = 15), preincubated (+D1R +CPZ; n = 12) or not (−D1R +CPZ; n = 10)
with chlorpromazine (CPZ; 1 µM). One-way ANOVA with Dunn’s post-test
versus −D1R −CPZ. n.s., nonstatistically significant. Data were expressed as
mean ± SEM, and dots represent individual data points.
Figure 4. Acute application of dopamine but not chlorpromazine in-
hibits CaV2.2 currents in transfected HEK293T cells. (A) Representative
traces of CaV2.2 currents from HEK293T cells transfected with CaV2.2,
CaVα2δ1, CaVβ3, and D1R (11 or 23 ng cDNA) before and after acute application
of dopamine (+DA; 10 µM) or chlorpromazine (+CPZ; 10 µM). (B)
Concentration-response curve for dopamine (+DA) and chlorpromazine
(+CPZ; n = 3, 1 µM and n = 4, 10 µM) effect on CaV2.2 currents (ICav2.2). Data
on dopamine effect were fitted with Hill equations for each D1R cDNA
amount used (EC50 = 2.023 µM for 11 ng, total n = 42, r2 = 0.77 and EC50 =
1.180 µM for 23 ng of D1R, total n = 61, r2= 0.86). EC50, half-maximal effective
concentration. Data were expressed as mean ± SEM.
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of acute application of chlorpromazine in this experimental
setting (Fig. 4), similar to our result on native currents (Fig. 1 F).
Together, our data from Figs. 2, 3, and 4 indicate that D1R con-
stitutive activity is required for CaV2.2 current increase and also
recapitulate our observations using chlorpromazine on native
CaV currents from mouse mPFC pyramidal neurons.
Previous studies reporting D1R agonist–independent activity
have used D1R mutants with diminished constitutive activity as
genetic tools (Zhang et al., 2014). We chose a single mutant,
D1RS199A, that displays a very low level of constitutive activity
but maintains the same expression levels and sensitivity to do-
pamine as WT D1R (Al-Fulaij et al., 2008). We first checked that
the expression level of YFP-tagged versions of WT and mutant
D1R were the same (Fig. 5 A). We also compared the inhibitory
effect of acute application of dopamine on CaV2.2 currents and
found no differences between D1RS199A and WT D1R in our
experimental conditions (Fig. 5 B). Next, we compared basal
CaV2.2 currents and found that D1RS199A failed to increase basal
CaV2.2 currents (Fig. 5 C). Thus, our data suggest that only
constitutively active D1R is capable of increasing CaV2.2 current.
Channel-receptor physical interaction is required for
D1R-induced increase of CaV2.2 currents
We next evaluated if the effect of D1R on CaV2.2 involves
physical channel-receptor interaction. This hypothesis arises
from published work proposing that D1R loop 2 and the proximal
region of CaV2.2 C terminus interact, stimulating the traffic of
CaV2.2 proteins to the cell membrane (Kisilevsky et al., 2008).
This report shows that a peptide with the sequence of D1R loop
2 competes with D1R for interaction with the channel, while
other peptides, including one with the D1R loop 1 sequence, do
not. Based on these observations, we assayed the effect of ex-
pressing either D1R loop 2 or 1 on the CaV2.2 current increase
caused by D1R coexpression. We found that D1R loop 2 indeed
occludes the current increase, while D1R loop 1 has no effect
(Figs. 6, A and B). We also assayed the effect of coexpressing a
277–amino acid peptide corresponding to the CaV2.2 C terminus
and found that this maneuver also prevents the current increase
by D1R coexpression (Fig. 6 C). Finally, we verified that the acute
inhibitory effect of dopamine in these experimental conditions
was intact (Fig. 6 D). These results indicate that the CaV2.2
current increase driven by D1R requires that constitutively ac-
tive D1R physically interact with CaV2.2.
D1R constitutive activity increases gating CaV2.2 currents
To explore if the increased CaV2.2 current that we observed in
transfected HEK293T cells is related to a higher channel density
at the plasma membrane, we recorded gating currents, a metric
of the number of functional channels expressed at the cell sur-
face. We recorded ON gating currents at the reversal potential
(around +60 mV) from a resting potential of −100 mV. We cal-
culated the charge movement as QON, normalized by the cell
capacitance (Castiglioni et al., 2006). We observed that D1R co-
expression increases the QON, and, consistent with our previous
results, D1R loop 2 coexpression and D1R replacement by
D1RS199A occluded this effect (Fig. 7 A). To demonstrate that the
Figure 5. D1RS199A mutant with impaired constitutive activity fails to increase CaV2.2 currents. (A) Photomicrographs and average YFP fluorescence
(D1R-YFP F) signal in the plasma membrane normalized by cell area (D1R-YFP in PM/area) in HEK293T cells transfected with D1R-YFP or D1RS199A-YFP. Green
and red signals originate from the YFP tag on D1R or D1RS199A and the plasma membrane marker CellMask (PM marker), respectively. Scale bar represents
1 µm. (B) Representative traces and averaged percentage of CaV2.2 current (ICav2.2) inhibition by dopamine (+DA; 10 µM) in HEK293T cells coexpressing CaV2.2,
CaVα2δ1, CaVβ3, and D1R (+D1R; n = 4) or D1RS199A (+D1RS199A; n = 4). (C) Representative traces and averaged ICav2.2 from HEK293T cells cotransfected with
CaV2.2, CaVα2δ1, CaVβ3, and either empty plasmid (−D1R; n = 11), D1R (+D1R; n = 10), or D1RS199A (+D1RS199A; n = 17). Student’s unpaired t test (A and B) and
one-way ANOVA with Tukey’s post-test (C). n.s., nonstatistically significant. Data were expressed as mean ± SEM, and dots represent individual data points.
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QON increase is not due to changes in the relative open probability,
we plotted raw QON values versus peak tail current for individual
cells (Wei et al., 1994; Jones et al., 1999; Takahashi et al., 2004;
Garza-Lopez et al., 2018) and found that the parameters from the
lineal regression fits for control cells (−D1R) and cells coexpressing
D1R (+D1R) are not different (Fig. 7 B). Taken together, our
experiments allow us to propose that D1R-CaV2.2 interaction is
required for the increase in CaV2.2 current that occurs when con-
stitutively active D1R is coexpressed. Additional biochemical ex-
periments are required to conclude that the current enhancement
by D1R constitutive activity correlates with a greater number of
functional CaV2.2 channels in the plasma membrane.
Figure 6. CaV2.2 current increases caused by D1R constitutive activity are prevented by coexpression of D1R loop 2 and CaV2.2 C terminus without
changes in dopamine-mediated CaV2.2 current inhibition in transfected HEK293T cells. (A) Representative traces and averaged CaV2.2 currents (ICav2.2)
from HEK293T cells cotransfected with CaV2.2, CaVα2δ1, CaVβ3, and either D1R (+D1R white bar; n = 18) or empty plasmid (−D1R white bar; n = 11), with (+D1R
gray bar; n = 20) or without (−D1R gray bar; n = 16) D1R loop 2 (0.2 µg cDNA per well). (B) Representative traces and averaged ICav2.2 from HEK293T cells
cotransfected with CaV2.2, CaVα2δ1, CaVβ3, and either D1R (+D1R white bar; n = 8) or empty plasmid (−D1R white bar; n = 9), with (+D1R gray bar; n = 19) or
without (−D1R gray bar; n = 15) D1R loop 1 (0.2 µg cDNA per well). (C) Representative traces and averaged CaV2.2 currents (ICav2.2) from HEK293T cells
cotransfected with CaV2.2, CaVα2δ1, CaVβ3, and either D1R (+D1R white bar; n = 21) or empty plasmid (−D1R white bar; n = 18), with (+D1R gray bar; n = 14) or
without (−D1R gray bar; n = 17) proximal portion of CaV2.2 C terminus containing plasmid (CaV2.2 CT; 0.2 µg cDNA per well). (D) Representative traces and
averaged percentage of inhibition of ICav2.2 by dopamine (+DA; 10 µM) in HEK293T cells coexpressing CaV2.2, CaVα2δ1, CaVβ3, and D1R (+D1R; n = 10), D1R
plus D1R loop 2 (+loop 2; n = 7), D1R plus D1R loop 1 (+loop 1; n = 6), and D1R plus CaV2.2 CT (+CaV2.2 CT; n = 2). One-way ANOVA with Dunn’s post-test
versus −D1R white bar (A and C) and versus +D1R (D); Kruskal-Wallis test with Dunn’s post-test versus −D1R white bar (B). n.s., nonstatistically significant.
Data were expressed as mean ± SEM, and dots represent individual data points.
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D1R constitutive activity effect on CaV2.2 requires Gs
protein activity
We explored the requirement of Gs, the main G protein reported
to couple to D1R, for the effect of D1R on CaV2.2 current. We first
evaluated the changes in cAMP values driven by dopamine in
our experimental system. We found that acute dopamine ap-
plication increases cAMP levels, reaching a maximum value in
140 s in cells expressing D1R or D1R plus the loop 2 peptide. We
also confirmed that chlorpromazine failed to increase cAMP in
both experimental conditions as expected for the acute appli-
cation of an inverse agonist (Fig. 8 A). We next quantified the
basal cAMP by radioimmunoassay and found that it has a ten-
dency to be larger in cells expressing D1R and is significantly
larger in cells coexpressing D1R and loop 2 than in control cells
(Fig. 8 B). These results suggest that Gs can be acutely activated
on top of its basal level of activity and that the loop 2 does not
alter Gs signaling. We next assayed the Gs inhibitor ChTx
(500 ng/ml) in HEK293T cells. We first corroborated that ChTx
occludes dopamine-induced inhibition of CaV2.2 currents in cells
coexpressing D1R and the channel (Fig. 8 C). Finally, we assessed
the effect of ChTx on basal currents and found that the toxin
abolishes the increase in CaV2.2 currents induced by D1R coex-
pression (Fig. 8 D). Taken together, our results suggest that D1R
constitutive activity signals through Gs, contributing to the in-
crease in CaV2.2 currents (Fig. 8).
Our results indicate that D1R would interact with CaV2.2,
increasing the amount of channels in plasma membrane de-
pending on its constitutive activity. On the other hand, previous
work that we have replicated here in part shows that dopamine-
mediated D1R activity reduces CaV2.2 currents and promotes
channel internalization (Huang and Zamponi, 2017). At this point,
an open question is: why do D1R constitutive and dopamine-
mediated activities have opposite effects? One possibility is
that D1R places more channels in the membrane in order to
amplify dopamine effects when it is released from near-
synaptic terminals. If this were true, we would expect that
in chlorpromazine-treated mice the capability of dopamine to
inhibit CaV2.2 channels would be reduced, since there would
be fewer channels available. In Fig. 9, we present data sup-
porting this thought. We recorded native currents from mPFC
neurons and reproduced the result from Fig. 1 showing that in
chlorpromazine-treated animals, basal native CaV currents were
reduced (Fig. 9 A). More importantly, the percentage of CaV cur-
rent inhibition by 10 µM SKF38393 was significantly reduced in
the chlorpromazine-treated group (Fig. 9 B).
Discussion
Here, we demonstrated that D1R constitutive activity increases
CaV2.2 currents in a heterologous expression system. Based on
our experiments using an inverse agonist and a D1R mutant
lacking constitutive activity, we conclude that basally active
D1Rs are required to increase CaV2.2 currents. Moreover, we
confirmed that D1R loop 2 and the CaV2.2 C terminus occlude
this effect, suggesting a direct interaction between D1R and the
channel. Surprisingly, we found that Gs activity is also required,
adding a new level of complexity to the mechanism. Taking into
account a previous report by the Zamponi laboratory (Kisilevsky
et al., 2008), we suggest that constitutively active D1R interacts
with CaV2.2, stabilizing functional channels in the plasma
membrane. In this context, active Gs protein could form part of
the constitutively active D1R-CaV2.2 complex, or it could be
exerting an additional effect by activating a cascade that some-
how modifies the channel or D1R.
Figure 7. D1R constitutive activity increases the number of functional CaV2.2 channels at the plasma membrane. (A) Individual (gray) and averaged
(black) traces of ON gating CaV2.2 currents (top panel) and averaged QON from HEK293T cells cotransfected with CaV2.2, CaVα2δ1, CaVβ3, and either D1R (+D1R
white bar; n = 17), D1RS199A (+D1RS199A white bar; n = 10), or empty plasmid (−D1R white bar; n = 10), with (+D1R gray bar; n = 5) or without (−D1R gray bar;
n = 10) D1R loop 2 (0.2 µg cDNA per well; bottom panel). Reversal potential (Vrev, ∼60mV) was estimated individually for each cell. (B) QON versus peak CaV2.2
tail current (Itail at −60 mV) plot for HEK293T cells coexpressing CaV2.2, CaVα2δ1, CaVβ3 with (+D1R black dots; n = 22, r2 = 0.61) or without D1R (−D1R open
dots; n = 22, r2 = 0.31). Lineal regression slopes are not different between the groups (P = 0.187; F = 1.798). One-way ANOVA with Tukey’s post-test (only
significant comparisons shown, A). Extra sum of squares F test (B). pF, picofaradays. Data were expressed as mean ± SEM, and dots represent individual data
points.
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Here, we propose that the chronic stimulatory effect of
D1R coexpression requires Gs participation that would occur
independently of Gs rapid activation by agonist binding to
D1R. Our data demonstrate that basal levels of cAMP are el-
evated in cells expressing D1R and that acute dopamine ap-
plication further increases these second messenger levels.
Moreover, we found that ChTx, a specific Gs inhibitor, pre-
vents CaV2.2 current increase by D1R coexpression as well as
dopamine-induced acute CaV2.2 current inhibition. These
opposite effects of D1R constitutive and dopamine-evoked
activities on CaV2.2 current resemble other reports demon-
strating that ORL-1 and D2R coexpression are capable of
physically interacting and promoting channel traffic toward
the plasma membrane, while the agonist-mediated activation
of these GPCRs acutely reduces CaV2.2 current (Huang and
Zamponi, 2017). Although it is not explored in these reports,
GPCRs’ constitutive activity could play a role in the basal
increase of CaV2.2 trafficking. Indeed, there is evidence
showing that ORL-1 (Beedle et al., 2004) and D2R (Akam and
Strange, 2004; Roberts and Strange, 2005) display basal
signaling. In the case of D2R, the constitutive activity is hard
to evidence because D2R is coupled to Gi/o, and thus it re-
duces cAMP levels. On the other hand, a recent publication
from our group suggests that D2R basal signaling through
Gβγ impacts CaV2.2 currents (Cordisco Gonzalez et al., 2020).
Thus, the dual opposite chronic and acute effects of D1R on
CaV2.2 may be an example of a common modulatory behavior
of some GPCRs.
We previously studied the effect of other basally active GPCRs
on CaV currents with contrasting results. Ghrelin receptor con-
stitutive activity reduces CaV2.2 forward trafficking from en-
doplasmic reticulum to plasma membrane and thus diminishes
the CaV2.2 current in a Gi/o-dependent manner (Mustafá et al.,
2017). On the other hand, melanocortin type 4 receptor reduces
CaV1.2, CaV1.3, and CaV2.1 currents without affecting CaV2.2.
Interestingly, melanocortin type 4 receptor is a Gs protein–
coupled receptor, but its constitutive pathway acting on CaV
currents is mediated by Gi/o (Agosti et al., 2014, 2017). This
discrepancy reveals high heterogeneity among the effects of
GPCR constitutive activity on CaV.
Figure 8. D1R-induced increase in CaV2.2 currents requires Gs activation. (A) Real-time cAMP time course recorded from HEK293T cells transfected with
D1R (+D1R; n = 3), D1R plus D1R loop 2 (+D1R + loop 2; n = 3), and empty plasmid (−D1R; n = 3) with acute application of 1 µM dopamine (DA; black circles), 1 µM
chlorpromazine (CPZ; white circles), and DMEM (gray triangles). Bars on the right represent R/Ro/540 s averaged values in the different conditions. (B) Basal
measurement of cAMP values in HEK293T cells transfected with D1R (+D1R; n = 6), D1R plus D1R loop 2 (+D1R + loop 2; n = 3), and empty plasmid (−D1R; n = 3).
(C) Representative traces and averaged percentage of inhibition of CaV2.2 currents (ICav2.2) by dopamine in HEK293T cells cotransfected with CaV2.2, CaVα2δ1,
CaVβ3, and D1R preincubated or not with 500 ng/ml ChTx (+D1R −ChTx; n = 6) and (+D1R +ChTx; n = 5). (D) Representative traces and averaged ICav2.2 from
HEK293T cells cotransfected with CaV2.2, CaVα2δ1, CaVβ3, and either D1R (+D1R −ChTx; n = 17) or empty plasmid (−D1R −ChTx; n = 12), preincubated or not
with ChTx (−D1R +ChTx; n = 11) and (+D1R +ChTx; n = 20). One-way ANOVA with Dunn’s post-test versus −D1R (A), versus +D1R (B), and versus −ChTx (C) and
Student’s unpaired t test (C). AUC, area under the curve; n.s., nonstatistically significant. Data were expressed as mean ± SEM, and dots represent individual
data points.
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Here, we found that injecting mice with IP chlorpromazine, an
inverse agonist of D1/D5R, dramatically reduces calcium currents in
mPFC neurons. By calculating the percentage of ω-conotoxin
GVIA–sensitive current relative to the total current affected by
chlorpromazine, we concluded that CaV2.2 accounts for∼37% of the
total calcium current reduced; thus, chlorpromazine also partially
decreases non–ω-conotoxin GVIA–sensitive currents. One plausible
explanation is that chlorpromazine acts directly on non-CaV2.2
subtypes of CaV. In this regard, an early work demonstrated that
chlorpromazine acutely reduces L-type calcium current in cultured
mouse neuroblastoma cells (Ogata et al., 1990). On the other hand,
non-CaV2.2 subtypes could also be sensitive to D1/D5R constitutive
activity. Further experiments are required to discriminate among
the possibilities of a direct effect of chlorpromazine on non-CaV2.2
subtypes, a contribution of D5R constitutive activity to the total
effect of chlorpromazine, and the targeting of non-CaV2.2 subtypes
by D1R constitutive activity.
The effect of D1R on CaV2.2 occurs quite rapidly in mouse
mPFC neurons. Less than 24 h are required to observe a current
reduction by chlorpromazine injection, a time range comparable
to the tens of hours reported for CaV2.2 turnover (Bernstein and
Jones, 2007; Simms and Zamponi, 2012). Moreover, it has been
described that the binding of dopamine induces both D1R and
CaV2.2 internalization (Kisilevsky et al., 2008), and another
study has shown that injection of methamphetamine, an in-
hibitor of dopamine reuptake, reduces CaV currents in a D1/
D5R–dependent manner (González et al., 2016). Thus, it is pos-
sible that constitutively active D1R interacts with CaV2.2, pre-
venting internalization and stabilizing the channel in the plasma
membrane, and that dopamine binding to D1R reverts this effect.
D1R-expressing neurons would thus display a highly dynamic
regulation of CaV2.2 expression at the cell surface.
One putative function of D1R constitutive activity is to help
specify CaV2.2 sub-cellular localization. D1R might play a role in
the noncanonical somatic and dendritic sub-localization of
CaV2.2. The receptor might also be part of a group of modulators
that localize CaV2.2 to postsynaptic sites, particularly in layer
V/VI pyramidal neurons of the mPFC. It was recently shown that
the collapsing response mediator protein 2 (CRMP2) augments
CaV2.2 protein in PFC neurons, an effect tied to cue reinstate-
ment after cocaine self-administration extinction (Buchta et al.,
2020). Thus, it is possible that CaV2.2, a typically presynaptic
calcium channel, is playing a noncanonical role at postsynaptic
sites in PFC neurons, and that D1R, among other modulators,
stabilizes CaV2.2 protein at these sites. Here, we showed that CaV
currents from animals IP injected with the D1R inverse agonist
chlorpromazine are less sensitive to SKF-mediated inhibition.
Considering that CaV2.2 is highly sensitive to G protein–signaling
cascades, we postulate that neurons expressing constitutively active
D1R would have larger calcium currents responsive to dopamine at
postsynaptic sites. Moreover, it has been reported that CaV2.2 lo-
calizes in dendrites in cortical pyramidal and Purkinje cerebellar
neurons (Westenbroek et al., 1992) and contributes to postsynaptic
calcium entry in lumbar spinal cord neurons (Heinke et al., 2004)
and dentate granule cells (Hamilton et al., 2010). It would be in-
teresting to explore the role of high-density CaV2.2 at PFC post-
synaptic sites in terms of its contribution to activity-mediated
postsynaptic calcium entry, dendrite calcium potentials, and long-
term plasticity.
Antipsychotic drugs are a large heterogeneous group of D1/
D5R inverse agonists that were initially described as D2R an-
tagonists (Cai et al., 1999; Martin et al., 2001). Our work pro-
poses that basally active D1R can be a functional target of these
drugs. Here, we used chlorpromazine, a typical antipsychotic
drug, and found that D1R constitutive activity plays a role in
controlling CaV2.2 current density. To our knowledge, this is the
first clear functional output of D1R constitutive activity. Besides
CaV2.2, other synaptic proteins may also be affected by D1R
constitutive activity. In particular, in hippocampal neurons,
NMDA receptors complex with D1R at perisynaptic sites, and
dopamine binding unleashes NMDA receptors, which migrate to
the synaptic sites and contribute to long-term potentiation
(Ladepeche et al., 2013). It would be interesting to study the role
of D1R constitutive activity in this mechanism. Meanwhile, D5R,
Figure 9. Sensitivity of CaV currents from mPFC neurons to D1/D5R agonist is reduced in chlorpromazine IP–treated mice. (A) Representative traces
and averaged normalized CaV currents (ICa) registered in mPFC from mice treated IP with vehicle (n = 9, four animals) or chlorpromazine (CPZ; 1 mg/kg; n = 6,
three animals). (B) Representative time courses of ICa and averaged percentage of ICa inhibition by SKF38393 (+SKF; 10 µM) in mPFC neurons from mice IP
treated with vehicle (n = 5, four animals) or chlorpromazine (CPZ; 1 mg/kg; n = 4, three animals). Student’s unpaired t test. Data were expressed as mean ±
SEM, and dots represent individual data points.
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the other D1-like receptor, also displays basal activity. In this
regard, the inhibition of D5R constitutive activity by flupen-
thixol, an atypical antipsychotic drug, depresses supranormal
burst firing in subthalamic neurons in a ratmodel of Parkinson’s
disease (Chetrit et al., 2013). Thus, the study of the cellular and
physiological effects of D1R-like receptor constitutive activity
may help to improve treatments that rely on available anti-
psychotics, as well as to develop more efficient drugs.
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